← Evidence map

ArticleLife science alliance2023

Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication.

Tobias Moll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36241425